Lgl Partners, LLC Sarepta Therapeutics, Inc. Transaction History

Lgl Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $19,065 - $22,987	186 Added 4.64%	4,196 $508,000
Q2 2023 Aug 02, 2023	BUY	$106.4 - $157.19 $39,368 - $58,160	370 Added 10.16%	4,010 $459,000
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $40,665 - $53,972	-346 Reduced 8.68%	3,640 $501,000
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $2,521 - $3,303	-25 Reduced 0.62%	3,986 $516,000
Q3 2022 Nov 09, 2022	BUY	$75.71 - $119.24 $303,672 - $478,271	4,011 New	4,011 $443,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Lgl Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Lgl Partners, LLC with notifications on news.